BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25163969)

  • 1. Oncogenic osteomalacia caused by phosphaturic mesenchymal tumours in the proximal and shaft of the tibia: a case report.
    Pithankuakul K; Ratanasuwan T; Thanakit V; Sukhantanak B; Kiatisevi P
    J Orthop Surg (Hong Kong); 2014 Aug; 22(2):257-62. PubMed ID: 25163969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphaturic mesenchymal tumor of the tibia with oncogenic osteomalacia in a teenager.
    Farmakis SG; Siegel MJ
    Pediatr Radiol; 2015 Aug; 45(9):1423-6. PubMed ID: 25721582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic osteomalacia associated with phosphaturic mesenchymal tumour, mixed connective tissue type of the knee.
    Szumera-Ciećkiewicz A; Ptaszyński K; Pawełas A; Rutkowski P
    Pol J Pathol; 2009; 60(4):193-8. PubMed ID: 20200786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphaturic mesenchymal tumour mixed connective tissue variant: report of three cases with unusual histological findings.
    Shustik DA; Ng DC; Sittampalam K
    Int J Clin Exp Pathol; 2015; 8(6):7506-17. PubMed ID: 26261662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occult phosphaturic mesenchymal tumour of femur cortex causing oncogenic osteomalacia - diagnostic challenges and clinical outcomes.
    Dutta D; Pandey RK; Gogoi R; Solanki N; Madan R; Mondal A; Dogra S; Thapa P
    Endokrynol Pol; 2018; 69(2):205-210. PubMed ID: 29442350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour-induced Osteomalacia Secondary to Intracranial Tumours - Report of 2 Cases.
    Gunawat PV; Shaikh ST; Deopujari CE
    J Assoc Physicians India; 2019 Apr; 67(4):85-86. PubMed ID: 31299850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oncogenic osteomalacia due to phosphaturic mesenchymal tumour in infratemporal fossa].
    Viscasillas G; Maiz J; Lao X; Zschaeck C; Sanz JJ
    Acta Otorrinolaringol Esp; 2010; 61(5):392-4. PubMed ID: 20172500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic Osteomalacia From a Primary Phosphaturic Mesenchymal Tumor of the Toe: A Case Report.
    Kim I; Rajani R
    J Foot Ankle Surg; 2016; 55(2):294-8. PubMed ID: 25441266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple phosphaturic mesenchymal tumors associated with oncogenic osteomalacia: case report and review of the literature.
    Peterson NR; Summerlin DJ; Cordes SR
    Ear Nose Throat J; 2010 Jun; 89(6):E11-5. PubMed ID: 20556724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tumor-induced osteomalacia caused by a late-revealing phosphaturic mesenchymal tumor].
    Chazal T; Khanine V; Lidove O; Godot S; Ziza JM
    Rev Med Interne; 2017 Jun; 38(6):412-415. PubMed ID: 27659744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of phosphaturic mesenchymal tumor.
    Pallavi R; Ravella PM; Gupta P; Popescu A
    Am J Ther; 2015; 22(2):e57-61. PubMed ID: 24247100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteomalacia-Inducing Tumors of the Brain: A Case Report, Review and a Hypothesis.
    Fathalla H; Cusimano M; Di Ieva A; Karamchandani J; Fung R; Kovacs K
    World Neurosurg; 2015 Jul; 84(1):189.e1-5. PubMed ID: 25746588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphaturic mesenchymal tumor: two contrasting cases.
    Koplas MC; Rubin BP; Sundaram M
    Skeletal Radiol; 2014 Jun; 43(6):841-5. PubMed ID: 24402445
    [No Abstract]   [Full Text] [Related]  

  • 14. Oncogenic hypophosphataemic osteomalacia: biomarker roles of fibroblast growth factor 23, 1,25-dihydroxyvitamin D3 and lymphatic vessel endothelial hyaluronan receptor 1.
    Hannan FM; Athanasou NA; Teh J; Gibbons CL; Shine B; Thakker RV
    Eur J Endocrinol; 2008 Feb; 158(2):265-71. PubMed ID: 18230836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic osteomalacia induced by a sinonasal tumour: case report and review.
    Kabtouri H; Karmali R; Spinato L; Khamaktchian M; Bisschop P
    B-ENT; 2014; 10(2):149-55. PubMed ID: 25090814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic osteomalacia due to phosphaturic mesenchymal tumour in the upper thoracic spine.
    Garg B; Mehta N; Goyal A; Khadgawat R
    BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33328210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic osteomalacia caused by a phosphaturic mesenchymal tumor of the oral cavity: a case report.
    Yang IM; Park YK; Hyun YJ; Kim DY; Woo JT; Kim SW; Kim JW; Kim YS; Choi YK
    Korean J Intern Med; 1997 Jan; 12(1):89-95. PubMed ID: 9159046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-Induced Osteomalacia: an Up-to-Date Review.
    Hautmann AH; Hautmann MG; Kölbl O; Herr W; Fleck M
    Curr Rheumatol Rep; 2015 Jun; 17(6):512. PubMed ID: 25900190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical treatment of recurrent spinal phosphaturic mesenchymal tumor-induced osteomalacia: A case report.
    Liu S; Zhou X; Song A; Huo Z; Wang Y; Liu Y
    Medicine (Baltimore); 2020 Jan; 99(4):e18603. PubMed ID: 31977851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracranial phosphaturic mesenchymal tumor, mixed connective tissue variant presenting without oncogenic osteomalacia.
    Bower RS; Daugherty WP; Giannini C; Parney IF
    Surg Neurol Int; 2012; 3():151. PubMed ID: 23372968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.